Price to Book Value Chart

View Price to Book Value for BVNKF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2005. Start Trial.
Date Value
September 18, 2026 1.224
September 17, 2026 1.224
September 16, 2026 1.224
September 15, 2026 1.224
September 14, 2026 1.224
September 11, 2026 1.224
September 10, 2026 1.224
September 09, 2026 1.224
September 08, 2026 1.224
September 04, 2026 1.224
September 03, 2026 1.224
September 02, 2026 1.224
September 01, 2026 1.224
August 31, 2026 1.224
August 28, 2026 1.224
August 27, 2026 1.224
August 26, 2026 1.224
August 25, 2026 1.224
August 24, 2026 1.224
August 21, 2026 1.224
August 20, 2026 1.040
August 19, 2026 1.040
August 18, 2026 1.040
August 17, 2026 1.040
August 14, 2026 1.040
Date Value
August 13, 2026 1.040
August 12, 2026 1.040
August 11, 2026 1.040
August 10, 2026 1.040
August 07, 2026 1.040
August 06, 2026 1.040
August 05, 2026 1.040
August 04, 2026 1.040
August 03, 2026 1.040
July 31, 2026 1.040
July 30, 2026 1.040
July 29, 2026 1.040
July 28, 2026 1.040
July 27, 2026 1.040
July 24, 2026 1.040
July 23, 2026 1.040
July 22, 2026 1.040
July 21, 2026 1.040
July 20, 2026 1.040
July 17, 2026 1.040
July 16, 2026 1.040
July 15, 2026 1.040
July 14, 2026 1.040
July 13, 2026 1.040
July 10, 2026 1.040

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Evaxion AS 2.862
Genmab A/S 3.482
Ascendis Pharma A/S 9.466
Zealand Pharma A/S 1.090
Agenus, Inc. --

Price to Book Value Related Metrics